Don't have an account?
GE HealthCare
In addition to providing excellent patient care, cardiologists must also prioritize lowering healthcare costs. Reducing wasteful spending will be a key driver of cardiology's economic sustainability moving forward, as overtreatment and low-value care account for $75.7 billion to $101.2 billion of healthcare's annual financial waste, according to JAMA.1 Investing in improving diagnostic accuracy through better ECG interpretation and other strategies can help cardiologists drive these costs down and improve patient care, saving money and, more importantly, lives.
Misdiagnoses are a common challenge in cardiology. One study published in Diagnosis found missed or delayed diagnosis rates of 2.2% for MI, 8.7% for stroke, 19.9% for venous thromboembolism, 23.9% for arterial thromboembolism, and 27.9% for aortic aneurysm and dissection.2 More specific factors, such as sex-based differences or even unconscious racial biases, have the potential to drive further diagnostic errors if they are left unchecked.
Such errors are costly. Another study in Diagnosis showed that diagnostic errors related to the top 5 vascular diseases alone led to more than $500 million in malpractice payouts over a 10-year span.3
False positives are another common diagnostic mistake. One study in Revista Española de Cardiología found that among STEMI network activations, 14.6% were angiographic false positives, meaning no culprit artery was identified, and 11.6% were clinical false positives, meaning the discharge diagnosis was not STEMI.4
Since the average cost of angioplasty is around $32,000, according to the Chicago Tribune—atop the fact that it can be a dangerous procedure for patients who aren't indicated for it—false-positive results could drive up wasteful costs and worsen patient outcomes.5
Misdiagnoses can also raise the risk of malpractice and associated legal costs. A study of cardiology-related malpractice litigation published in Cureus showed that the two most common reasons for litigation were failure to treat (77.7%) and failure to diagnose (69.3%), with MI being the most frequently missed diagnosis.6 One 25-year study reported by Becker's Hospital Review quantified the inflation-adjusted cost of diagnostic error claims (as of 2016) at $386,849 per malpractice case.7
Investing in diagnostic ECG can make a substantial difference in caring for patients and reducing costs. As an efficient, lightweight, and affordable technology that can be available at the bedside, a 12-lead ECG can help ensure prompt and correct treatment when patients need it.
As with any other diagnostic technology, however, ECG accuracy depends on interpretation. If providers misread ECGs, it can negatively affect patient care and drive up unnecessary costs.
For example, one study in JRSM Cardiovascular Disease noted that up to 72% of unnecessary catheterization activations have been linked to ECG misinterpretation.8 At least in part, these misreadings may be due to the fact that ST elevations can present in other non-MI clinical contexts, such as pericarditis, myocarditis, right bundle branch block, stress cardiomyopathy (Takotsubo), acute vasospasm, and left ventricular hypertrophy, as a Cureus review notes.9
These misinterpretation rates should not undermine the utility of taking prehospital or in-hospital ECGs. The European Society of Cardiology recommends evaluating patients with suspected STEMI with a 12-lead ECG as soon as possible at the time of first medical contact in order to speed diagnosis and triage.10 If the results are unclear or don't support a diagnosis of MI, ECGs should be repeated and compared with prior readings whenever possible.
Providers should also take advantage of available resources for ECG interpretation from manufacturers, including educational materials and activities, given the significance of maintaining competency in ECG interpretation through continuous training.
Now more than ever, creative approaches to virtual learning may help bridge knowledge gaps as well. In a 2019 study of EMS personnel in CJC Open, for example, ECG diagnostic accuracy improved by 10.4% after the roll-out of an online case review program.11
Given its large proportion of expenditures in relation to total healthcare costs, cardiology has a unique opportunity to cut unnecessary spending and drive revenue from value-based care simultaneously. With results available in minutes at the point of care, ECG, in experienced hands, has significant potential to drive down costs and improve patient care. Anthony Kashou, MD, also known as "The EKG Guy," stresses the importance of physicians becoming sufficiently trained in ECG interpretation to avoid putting themselves and their patients at a disadvantage.
Every minute is precious in cardiac care, and as healthcare practices and patients continue to reel from the economic effects of COVID-19, managing costs remains a critical consideration as well.